日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tralokinumab Effectively Disrupts the IL-13/IL-13Rα1/IL-4Rα Signaling Complex but Not the IL-13/IL-13Rα2 Complex

Tralokinumab 可有效破坏 IL-13/IL-13Rα1/IL-4Rα 信号复合物,但不能破坏 IL-13/IL-13Rα2 复合物

Maxim A X Tollenaere, Christina Mølck, Ian Henderson, Scott Pollack, Philip Addis, Helle Heibroch Petersen, Hanne Norsgaard

Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington's Disease

5-(三氟甲基)-1,2,4-恶二唑类 IIa HDAC 抑制剂对亨廷顿氏病的疗效评估

Andrew J Stott, Michel C Maillard, Vahri Beaumont, David Allcock, Omar Aziz, Alexander H Borchers, Wesley Blackaby, Perla Breccia, Gillian Creighton-Gutteridge, Alan F Haughan, Rebecca E Jarvis, Christopher A Luckhurst, Kim L Matthews, George McAllister, Scott Pollack, Elizabeth Saville-Stones, Aman

Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B

硫酸肝素是抑制性巨核细胞血小板受体 G6b-B 的关键调节剂

Timo Vögtle, Sumana Sharma, Jun Mori, Zoltan Nagy, Daniela Semeniak, Cyril Scandola, Mitchell J Geer, Christopher W Smith, Jordan Lane, Scott Pollack, Riitta Lassila, Annukka Jouppila, Alastair J Barr, Derek J Ogg, Tina D Howard, Helen J McMiken, Juli Warwicker, Catherine Geh, Rachel Rowlinson, W Ma

Discussion Strategies That Primary Care Clinicians Use When Stopping Cancer Screening in Older Adults

初级保健临床医生在停止老年人癌症筛查时使用的讨论策略

Schoenborn, Nancy L; Bowman, Theron L 2nd; Cayea, Danelle; Boyd, Cynthia; Feeser, Scott; Pollack, Craig E

Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3

发现、合成和表征口服生物可利用的脑渗透性混合谱系激酶 3 抑制剂

Val S Goodfellow, Colin J Loweth, Satheesh B Ravula, Torsten Wiemann, Thong Nguyen, Yang Xu, Daniel E Todd, David Sheppard, Scott Pollack, Oksana Polesskaya, Daniel F Marker, Stephen Dewhurst, Harris A Gelbard